1,1-dichloroethene decreases expression ISO RGD:62310 6480464 vinylidene chloride results in decreased expression of PPP1R1A mRNA CTD PMID:26682919 17alpha-ethynylestradiol multiple interactions ISO RGD:62310 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP1R1A mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:737038 6480464 Estradiol results in decreased expression of PPP1R1A mRNA CTD PMID:20106945 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PPP1R1A mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO RGD:62310 6480464 Estradiol results in decreased expression of PPP1R1A mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737038 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R1A mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62310 6480464 Tetrachlorodibenzodioxin affects the expression of PPP1R1A mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62310 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP1R1A mRNA CTD PMID:17942748 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPP1R1A mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPP1R1A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:737038 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PPP1R1A gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression ISO RGD:62310 6480464 Fenretinide results in decreased expression of PPP1R1A mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PPP1R1A mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PPP1R1A mRNA CTD PMID:30047161 aflatoxin B1 affects expression ISO RGD:737038 6480464 Aflatoxin B1 affects the expression of PPP1R1A protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:737038 6480464 Aflatoxin B1 results in decreased expression of PPP1R1A mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:737038 6480464 Aflatoxin B1 results in decreased methylation of PPP1R1A gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:737038 6480464 Tretinoin results in decreased expression of PPP1R1A mRNA CTD PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPP1R1A mRNA CTD PMID:16483693 benzo[a]pyrene decreases expression ISO RGD:737038 6480464 Benzo(a)pyrene results in decreased expression of PPP1R1A mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases methylation ISO RGD:737038 6480464 Benzo(a)pyrene results in increased methylation of PPP1R1A promoter CTD PMID:27901495 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of PPP1R1A mRNA CTD PMID:26496021 bisphenol A multiple interactions ISO RGD:737038 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PPP1R1A gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPP1R1A mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases methylation ISO RGD:62310 6480464 bisphenol A results in increased methylation of PPP1R1A promoter CTD PMID:27312807 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PPP1R1A gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPP1R1A mRNA CTD PMID:25181051 more ... chlordecone increases expression ISO RGD:62310 6480464 Chlordecone results in increased expression of PPP1R1A mRNA CTD PMID:33711761 ciguatoxin CTX1B affects expression ISO RGD:62310 6480464 Ciguatoxins affects the expression of PPP1R1A mRNA CTD PMID:18353800 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of PPP1R1A mRNA CTD PMID:15860345 cyclosporin A decreases expression ISO RGD:737038 6480464 Cyclosporine results in decreased expression of PPP1R1A mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:737038 6480464 Cyclosporine results in increased expression of PPP1R1A mRNA CTD PMID:27989131 dexamethasone increases expression ISO RGD:737038 6480464 Dexamethasone results in increased expression of PPP1R1A mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:737038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPP1R1A mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPP1R1A mRNA CTD PMID:28628672 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PPP1R1A mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:737038 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PPP1R1A mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:737038 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R1A mRNA CTD PMID:27188386 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of PPP1R1A mRNA CTD PMID:18035473 folic acid decreases expression ISO RGD:62310 6480464 Folic Acid results in decreased expression of PPP1R1A mRNA CTD PMID:25629700 fonofos increases methylation ISO RGD:737038 6480464 Fonofos results in increased methylation of PPP1R1A promoter CTD PMID:22847954 fulvestrant multiple interactions ISO RGD:737038 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PPP1R1A gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of PPP1R1A mRNA CTD PMID:27387713 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PPP1R1A mRNA CTD PMID:22061828 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of PPP1R1A mRNA CTD PMID:15860345 indometacin multiple interactions ISO RGD:737038 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPP1R1A mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPP1R1A mRNA CTD PMID:28628672 mercury dibromide decreases expression ISO RGD:737038 6480464 mercuric bromide results in decreased expression of PPP1R1A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:737038 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R1A mRNA CTD PMID:27188386 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of PPP1R1A mRNA CTD PMID:30047161 methylmercury chloride decreases expression ISO RGD:737038 6480464 methylmercuric chloride results in decreased expression of PPP1R1A mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate affects expression ISO RGD:62310 6480464 mono-(2-ethylhexyl)phthalate affects the expression of PPP1R1A mRNA CTD PMID:21195148 Monobutylphthalate affects expression ISO RGD:62310 6480464 monobutyl phthalate affects the expression of PPP1R1A mRNA CTD PMID:21195148 N-methyl-4-phenylpyridinium increases expression ISO RGD:737038 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PPP1R1A mRNA CTD PMID:24810058 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of PPP1R1A mRNA CTD PMID:15010824 N-Nitrosopyrrolidine decreases expression ISO RGD:737038 6480464 N-Nitrosopyrrolidine results in decreased expression of PPP1R1A mRNA CTD PMID:32234424 nickel atom decreases expression ISO RGD:737038 6480464 Nickel results in decreased expression of PPP1R1A mRNA CTD PMID:25583101 O-methyleugenol decreases expression ISO RGD:737038 6480464 methyleugenol results in decreased expression of PPP1R1A mRNA CTD PMID:32234424 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of PPP1R1A mRNA CTD PMID:23665939 panobinostat multiple interactions ISO RGD:737038 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R1A mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:737038 6480464 panobinostat results in increased expression of PPP1R1A mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:737038 6480464 Acetaminophen results in decreased expression of PPP1R1A mRNA CTD PMID:26690555 , PMID:29067470 paracetamol increases expression ISO RGD:737038 6480464 Acetaminophen results in increased expression of PPP1R1A mRNA CTD PMID:21420995 parathion increases methylation ISO RGD:737038 6480464 Parathion results in increased methylation of PPP1R1A promoter CTD PMID:22847954 perfluorononanoic acid decreases expression ISO RGD:737038 6480464 perfluoro-n-nonanoic acid results in decreased expression of PPP1R1A mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid affects expression ISO RGD:62310 6480464 perfluorooctane sulfonic acid affects the expression of PPP1R1A mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:62310 6480464 perfluorooctanoic acid affects the expression of PPP1R1A mRNA CTD PMID:19429403 phenylmercury acetate decreases expression ISO RGD:737038 6480464 Phenylmercuric Acetate results in decreased expression of PPP1R1A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737038 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R1A mRNA CTD PMID:27188386 progesterone decreases expression ISO RGD:737038 6480464 Progesterone results in decreased expression of PPP1R1A mRNA CTD PMID:21540246 quercetin decreases expression ISO RGD:737038 6480464 Quercetin results in decreased expression of PPP1R1A mRNA CTD PMID:15309432 resveratrol multiple interactions ISO RGD:737038 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PPP1R1A mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO RGD:737038 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:737038 6480464 Silicon Dioxide analog results in decreased expression of PPP1R1A mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:62310 6480464 Silver results in decreased expression of PPP1R1A mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:62310 6480464 Silver results in decreased expression of PPP1R1A mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:737038 6480464 sodium arsenite results in decreased expression of PPP1R1A mRNA CTD PMID:29301061 sodium fluoride increases expression ISO RGD:62310 6480464 Sodium Fluoride results in increased expression of PPP1R1A mRNA CTD PMID:27862939 sunitinib decreases expression ISO RGD:737038 6480464 Sunitinib results in decreased expression of PPP1R1A mRNA CTD PMID:31533062 terbufos increases methylation ISO RGD:737038 6480464 terbufos results in increased methylation of PPP1R1A promoter CTD PMID:22847954 testosterone decreases expression ISO RGD:62310 6480464 Testosterone results in decreased expression of PPP1R1A mRNA CTD PMID:20403060 testosterone decreases expression ISO RGD:737038 6480464 Testosterone results in decreased expression of PPP1R1A mRNA CTD PMID:33359661 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of PPP1R1A mRNA CTD PMID:26496021 thalidomide decreases expression ISO RGD:62310 6480464 Thalidomide results in decreased expression of PPP1R1A mRNA CTD PMID:26217789 titanium dioxide decreases expression ISO RGD:62310 6480464 titanium dioxide results in decreased expression of PPP1R1A mRNA CTD PMID:23557971 trichostatin A increases expression ISO RGD:737038 6480464 trichostatin A results in increased expression of PPP1R1A mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:737038 6480464 Triclosan results in decreased expression of PPP1R1A mRNA CTD PMID:30510588 triphenyl phosphate increases expression ISO RGD:737038 6480464 triphenyl phosphate results in increased expression of PPP1R1A mRNA CTD PMID:28934090 troglitazone increases expression ISO RGD:737038 6480464 troglitazone results in increased expression of PPP1R1A mRNA CTD PMID:28934090 valproic acid affects expression ISO RGD:737038 6480464 Valproic Acid affects the expression of PPP1R1A mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:737038 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R1A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737038 6480464 Valproic Acid results in increased expression of PPP1R1A mRNA CTD PMID:23179753 more ... vancomycin increases expression ISO RGD:62310 6480464 Vancomycin results in increased expression of PPP1R1A mRNA CTD PMID:18930951 zoledronic acid decreases expression ISO RGD:737038 6480464 zoledronic acid results in decreased expression of PPP1R1A mRNA CTD PMID:24714768